The Society of Nuclear Medicine and Molecular Imaging (SNMMI) presents the Prostate Cancer Imaging and Therapy curriculum. In this continuing education session, Dr. Ephraim Parent joins Dr. Phil Koo to present and discuss bone imaging and the role in prostate cancer, specifically bone scintigraphy. His presentation outlines an overview of Radiopharmaceuticals that are used for bone imaging,…
Ali Sabbagh presents a novel study on using machine learning to predict overall survival in clinical trials for metastatic prostate cancer. Dr. Sabbagh explains that…
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Rana…
Zach Klaassen interviews Jack Tay about the evolution and current practices in focal therapy for prostate cancer. Dr. Tay discusses the precision and reduced toxicity…
Kassem Faraj delves into the impact of the 340B program on advanced prostate cancer drugs in a recent study. Highlighting the shift towards oral-targeted therapies,…
Deepak Kilari discusses a Phase II trial exploring the combination of enzalutamide with five alpha-reductase inhibitors (ARIs) for castrate-sensitive prostate cancer. Driven by observations from…
Alicia Morgans hosts a multidisciplinary discussion with David Morris and Benjamin Garmezy focusing on the treatment of newly diagnosed metastatic hormone-sensitive prostate cancer (mHSPC). Dr.…
Zach Klaassen discusses the evolving landscape of non-metastatic castration-resistant prostate cancer (nmCRPC) with Neal Shore. They delve into the significant impact of PSMA PET scans…
Sam Chang engages with Ashish Kamat to discuss integrating Adstiladrin into regular clinical practice. During their conversation, Dr. Kamat elaborates on Adstiladrin’s journey from clinical…
Sam Chang introduces a dialogue with John Gore and Angie Smith, who are leading a trial named CISTO, aimed at addressing treatment decisions in non-muscle…
